Table 2.
Cytokine (pg/mL) |
Tertile 1 |
Tertile 2 |
Tertile 3 |
p† |
||
---|---|---|---|---|---|---|
Model 1 | Model 22,3,4 | Model 35,6,7 | ||||
|
Serum ascorbic acid |
|
||||
IL-1RA |
310.67 ± 11.46 |
329.51 ± 9.6 |
326.03 ± 9.75 |
0.0624 |
0.0468 |
0.0413 |
IFN-γ |
179.79 ± 7.33a |
204.95 ± 7.42b |
204.23 ± 7.15b |
0.0006 § |
0.0002 § |
0.0002 § |
IP-10 |
594.67 ± 27.52 |
604.55 ± 22.24 |
590.56 ± 20.54 |
0.5878 |
0.5341 |
0.558 |
PDGF-bb |
1220.29 ± 132.69 |
1136.53 ± 84.63 |
1251.47 ± 114.75 |
0.0686 |
0.0788 |
0.0787 |
RANTES |
2529.99 ± 91.78 |
2490.87 ± 147.66 |
2295.8 ± 83.83 |
0.3554 |
0.4747 |
0.4962 |
|
Plasma α-tocopherol |
|
||||
IL-1RA |
339.87 ± 12.67 |
317.07 ± 9.97 |
309.71 ± 7.54 |
0.0466 |
0.0248 |
0.0247 |
IFN-γ |
211.83 ± 7.83a |
197.65 ± 8.16b |
179.97 ± 5.67b |
0.0018 |
0.0004 § |
0.0003 § |
IP-10 |
608.78 ± 22.85 |
586.16 ± 23.07 |
595.28 ± 24.77 |
0.1821 |
0.1423 |
0.143 |
PDGF-bb |
1390.83 ± 167.45 |
1150.59 ± 85.74 |
1064.07 ± 44.17 |
0.7387 |
0.7313 |
0.7341 |
RANTES |
2556.83 ± 105.39a |
2524.51 ± 150.75a |
2238.31 ± 65.6b |
<0.0001 § |
<0.0001 § |
<0.0001 § |
|
Plasma 25(OH)D |
|
||||
IL-1RA |
324.23 ± 10.04 |
315.19 ± 10.38 |
327.19 ± 10.45 |
0.5194 |
0.4750 |
0.5239 |
IFN-γ |
203.68 ± 7.97 |
187.19 ± 6.2 |
198.56 ± 7.69 |
0.2111 |
0.1626 |
0.2214 |
IP-10 |
593.58 ± 28.78 |
562.99 ± 18.05 |
633.61 ± 22.56 |
0.4381 |
0.4366 |
0.4027 |
PDGF-bb |
1050.22 ± 81.85 |
1260.6 ± 148.14 |
1293.67 ± 92.93 |
0.9075 |
0.8993 |
0.9023 |
RANTES | 2174.88 ± 62.99 | 2427.65 ± 167.06 | 2715.98 ± 77.22 | 0.0561 | 0.0523 | 0.0236 |
1)Shown are crude, untransformed means ± standard errors.
†: p-value from ANCOVA with loge- or square-root transformed cytokine and vitamin concentrations where necessary.
Model 1: adjusted for age, sex, ethnicity, waist circumference, physical activity, season, total cholesterol, and hormonal contraceptive use among women.
Model 2: 2)For ascorbic acid, adjusted for the covariates listed in Model 1 plus serum α-tocopherol; 3)For α-tocopherol, adjusted for Model 1 plus ascorbic acid; 4)For 25(OH)D, adjusted for Model 1 plus ascorbic acid.
Model 3: 5)For ascorbic acid, adjusted for Model 2 plus 25(OH)D; 6)For α-tocopherol, adjusted for Model 2 plus 25(OH)D; 7)For 25(OH)D, adjusted for Model 2 plus α-tocopherol.
§: These p-values meet the Bonferroni level of significance for 45 tests (p = 0.0011; α = 0.05; 5 cytokines x 3 vitamins x 3 models).
a,b,c: Superscript letters indicate significant differences in cytokine concentrations between tertiles (p < 0.05), after adjustment for all covariates included in Model 3. The Tukey-Kramer procedure was used to adjust for multiple comparisons between groups within each ANCOVA. These post-hoc comparisons were only performed when Model p-values met the Bonferroni level of significance.